Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.95B |
| 2 |
NVIDIA
NVDA
|
+$1.63B |
| 3 |
Visa
V
|
+$1.09B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.05B |
| 5 |
Amazon
AMZN
|
+$917M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.48B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.36B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.06B |
| 4 |
iShares MSCI India ETF
INDA
|
+$827M |
| 5 |
iShares MBS ETF
MBB
|
+$767M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.58% |
| 2 | Consumer Discretionary | 2.07% |
| 3 | Financials | 1.9% |
| 4 | Healthcare | 1.47% |
| 5 | Industrials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OGI
8751
Organigram Holdings
OGI
$139M
| $74.8K | ﹤0.01% |
48,468
+23,909
| +97% | +$43.4K |
|
|
LAC
8752
PUT
Lithium Americas
LAC
$1.17B
| $74.5K | ﹤0.01% |
27,800
+500
| +2% | +$2.21K |
|
8753
CALL
Equinox Gold
EQX
$13.5B
| $74.3K | ﹤0.01% |
+14,200
| New | +$79K |
|
8754
Candel Therapeutics
CADL
$776M
| $74.2K | ﹤0.01% |
+11,960
| New | +$89.8K |
|
|
ADAP
8755
DELISTED
Adaptimmune Therapeutics
ADAP
| $73.7K | ﹤0.01% |
+75,576
| New | +$82.9K |
|
8756
CALL
AbCellera Biologics
ABCL
$2.12B
| $73.1K | ﹤0.01% |
24,700
-13,200
| -35% | -$49.9K |
|
8757
PUT
SSR Mining
SSRM
$6.48B
| $73.1K | ﹤0.01% |
16,200
-11,900
| -42% | -$61K |
|
|
TRSG
8758
Tungray Technologies
TRSG
$23.9M
| $72.9K | ﹤0.01% |
+18,844
| New | +$94K |
|
8759
Empire Petroleum
EP
$111M
| $72.7K | ﹤0.01% |
+14,095
| New | +$84.7K |
|
8760
PUT
ICL Group
ICL
$6.85B
| $71.7K | ﹤0.01% |
16,600
-400
| -2% | -$1.88K |
|
8761
Pluri
PLUR
$19.6M
| $71.6K | ﹤0.01% |
12,383
+8,396
| +211% | +$47.4K |
|
8762
Rallybio
RLYB
$85.8M
| $71.1K | ﹤0.01% |
+6,635
| New | +$89.9K |
|
8763
X4 Pharmaceuticals
XFOR
$460M
| $70.8K | ﹤0.01% |
4,072
+1,490
| +58% | +$48.7K |
|
8764
PUT
Lumen
LUMN
$6.44B
| $70.8K | ﹤0.01% |
64,400
-152,800
| -70% | -$194K |
|
8765
BioVie
BIVI
$7.54M
| $70.6K | ﹤0.01% |
+1,762
| New | +$84.3K |
|
|
DHY
8766
Credit Suisse High Yield Credit Fund
DHY
$240M
| $70.1K | ﹤0.01% |
34,703
+20,887
| +151% | +$42.5K |
|
|
NVOS
8767
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
| $69.7K | ﹤0.01% |
+92,989
| New | +$59.5K |
|
8768
Werewolf Therapeutics
HOWL
$19.3M
| $69.7K | ﹤0.01% |
28,580
-128,646
| -82% | -$618K |
|
|
MTTR
8769
CALL
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $69.7K | ﹤0.01% |
+15,600
| New | +$59.1K |
|
|
OLPX
8770
DELISTED
Olaplex Holdings
OLPX
| $69.6K | ﹤0.01% |
45,181
-783,088
| -95% | -$1.25M |
|
8771
Humacyte Inc Warrant
HUMAW
$1.24M
| $69.5K | ﹤0.01% |
50,000
| – | – |
|
|
INFN
8772
PUT
DELISTED
Infinera Corporation Common Stock
INFN
| $69.4K | ﹤0.01% |
+11,400
| New | +$60.3K |
|
|
NEXN
8773
Nexxen International
NEXN
$607M
| $69K | ﹤0.01% |
+12,275
| New | +$71.7K |
|
|
EXK
8774
CALL
Endeavour Silver
EXK
$2.83B
| $68.3K | ﹤0.01% |
19,400
+4,100
| +27% | +$13.3K |
|
8775
KULR Technology Group
KULR
$135M
| $68.1K | ﹤0.01% |
+21,545
| New | +$77.2K |
|
Similar funds
Jane Street's Q2 2024 Portfolio in Review
As of Q2 2024, Jane Street held 10,566 positions worth $438B, down 8.5% from $478B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Jane Street withdrew a net $64.5B in Q2 2024, closing 1,331 positions and reducing 3,257 holdings. Its most notable exit was iShares MSCI EAFE Small-Cap ETF, an estimated $254M position sold in full.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jane Street opened a new position in iShares Bitcoin Trust worth $221M.
- Jane Street's largest Q2 2024 buy was iShares Bitcoin Trust: 6,474,742 shares worth $221M.
- Jane Street added most to Apple in Q2 2024, an estimated $2.95B increase.
- Jane Street's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.48B.
- Jane Street fully exited iShares MSCI EAFE Small-Cap ETF in Q2 2024, selling an estimated $254M.
- Jane Street's ten largest holdings make up 43% of its $438B portfolio in Q2 2024.
- Jane Street opened 1,468 new positions and closed 1,331 in Q2 2024.
- Jane Street's portfolio value fell 8.5% quarter-over-quarter to $438B.
Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.